Zhenqiang Yao

5.1k citations
48 papers · 4.0k indexed · 1 hit paper · h-index 30

Zhenqiang Yao

48 papers receiving 4.0k citations

Hit Papers

Regulation of TNF-Induced Osteoclast Differentiation186202120262022202450100150

Peers

Zhenqiang Yao
Comparison fields: 5 of 115
  • Orthopedics and Sports Medicine 679
  • Oncology 1.4k
  • Cancer Research 759
  • Rheumatology 717
  • Molecular Biology 2.6k
Replace Noriyoshi Kurihara with:
Noriyoshi Kurihara United States
Jean‐Pierre David Germany
Yoshiyuki Hakeda Japan
Masamichi Takami Japan
Xijie Yu China
Xu Feng United States
Haibo Zhao United States
Akiko Kukita Japan
Marina Stolina United States
Silvia Hayer Austria
Zhenqiang Yao relative to Noriyoshi Kurihara United States Noriyoshi Kurihara's profile →
Citations per field
00.5×4.7×
Noriyoshi Kurihara · 1×
Citations per year

Countries citing papers authored by Zhenqiang Yao

Since Specialization
Citations

This map shows the geographic impact of Zhenqiang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenqiang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenqiang Yao more than expected).

Fields of papers citing papers by Zhenqiang Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenqiang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenqiang Yao. The network helps show where Zhenqiang Yao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zhenqiang Yao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhenqiang Yao Line = papers co-authored together Zhenqiang Yao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20249
2 20244
3 202326
4 202210
5 202213
6 20221
7 20201
8 202036
9 201970
10 201859
11 201827
12 201633
13 201317
14 2009127
15 200888
16 200727
17 2007366
18 2006167
19 2006366
20 200586

About Zhenqiang Yao

Zhenqiang Yao is a scholar working on Oncology, Orthopedics and Sports Medicine and Cancer Research, having authored 48 papers that have together received 4.0k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (37 papers), Bone health and treatments (27 papers), NF-κB Signaling Pathways (14 papers), Bone and Joint Diseases (8 papers), TGF-β signaling in diseases (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (679 citations), Oncology (1.4k citations) and Cancer Research (759 citations). Zhenqiang Yao has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Brendan F. Boyce, Lianping Xing, Edward M. Schwarz, Qian Zhang, Yan Xiu, I.R. Badell, Stephen J. Getting, Ian C. Locke, Jinbo Li and Jinbo Li. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026